Hyperbaric Oxygen Therapy for Sudden Sensorineural Hearing Loss | Otolaryngology | JN Learning | AMA Ed Hub [Skip to Content]
[Skip to Content Landing]

Hyperbaric Oxygen Therapy for Patients With Sudden Sensorineural Hearing LossA Systematic Review and Meta-analysis

Educational Objective
To evaluate the current literature on the effectiveness of hyperbaric oxygen therapy in patients with sudden sensorineural hearing loss.
1 Credit CME
Key Points

Question  What is the prospective randomized controlled trial evidence for using hyperbaric oxygen therapy (HBOT) as a single or combination therapy for improving hearing outcomes for patients with sudden sensorineural hearing loss (SSNHL) compared with control treatments?

Findings  This systematic review and meta-analysis included 3 prospective randomized controlled trials with a total of 88 participants who received HBOT in intervention groups and 62 participants who received routine treatment in the control groups. The meta-analysis found a significant mean difference in absolute hearing gain and odds ratio for hearing recovery following HBOT, favoring the intervention.

Meaning  The findings of this systematic review and meta-analysis suggest that clinicians treating patients with SSNHL should consider including HBOT as part of a combination treatment regimen.

Abstract

Importance  Sudden sensorineural hearing loss (SSNHL) is an acute, usually unilateral deficit. Systemic and intratympanic steroids are accepted treatments. Although evidence suggests that hyperbaric oxygen therapy (HBOT) may be beneficial, it is not widely offered.

Objectives  To review and evaluate recent evidence of the association of HBOT with hearing outcomes in SSNHL and to determine if HBOT should be a single or part of a combination treatment regimen.

Data Sources  Cochrane Central Register of Controlled Trials, PubMed, EMBASE, CINAHL, Web of Science, CAB, ICTRP, Google Scholar, Clinicaltrials.gov, and ISRCTN databases were searched for randomized controlled trials (RCTs) published in English from January 1, 2000, and April 30, 2020.

Study Selection  Prospective RCTs involving only adult participants (≥18 years) with SSNHL and comparing HBOT, as a single or combination therapy, with control therapies, such as steroids and/or placebo. Only RCTs that used the American Academy of Otolaryngology–Head and Neck Surgery’s diagnostic criteria for SSNHL were included.

Data Extraction and Synthesis  Data were extracted independently by 2 researchers. A fixed-effects model was used for analysis and performed from November 30, 2020, to May 20, 2021.

Main Outcomes and Measures  The mean difference in absolute hearing gain recorded by pure-tone audiometric (PTA) thresholds averaged across 4 low (0.5, 1, 2, and 3 or 4 kHz) or 3 high (3 or 4, 6, and 8 kHz) frequencies was the primary outcome. The secondary outcomes were the odds ratio of hearing recovery defined as a hearing gain of ≥10 decibels (dB) in PTA average and treatment-related adverse effects.

Results  Of the 826 records initially identified, 358 duplicates and 451 articles were excluded based on article type, title, and abstract. The full texts of 17 articles were reviewed, of which 14 were excluded because they were either not prospective RCTs (11 articles), the participants were less than 18 years old (2 articles), or the PTA was not reported at frequencies of interest (1 article). Three prospective RCTs with a total of 88 participants who received HBOT in the intervention groups and 62 participants who received only medical therapy in the control groups were studied. The intergroup difference in mean absolute hearing gain (mean difference, 10.3 dB; 95% CI, 6.5-14.1 dB; I2 = 0%) and the odds ratio of hearing recovery (4.3; 95% CI, 1.6-11.7; I2 = 0%) favored HBOT over the control therapy.

Conclusions and Relevance  In this systematic review and meta-analysis, HBOT as part of a combination treatment was significantly associated with improved hearing outcomes in patients with SSNHL over control treatments.

Trial Registration  PROSPERO Identifier: CRD42020193191

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Accepted for Publication: August 4, 2021.

Published Online: October 28, 2021. doi:10.1001/jamaoto.2021.2685

Corresponding Author: Desmond A. Nunez, MD, MBA, Division of Otolaryngology, Department of Surgery, University of British Columbia, Diamond Health Care Centre, 2775 Laurel St, 4th Floor, Vancouver, BC V5Z 1M9, Canada (desmond.nunez@ubc.ca).

Author Contributions: Drs Nunez and Joshua had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Joshua, Ayub, Nunez.

Acquisition, analysis, or interpretation of data: All authors.

Drafting of the manuscript: Joshua, Ayub.

Critical revision of the manuscript for important intellectual content: Joshua, Wijesinghe, Nunez.

Statistical analysis: Joshua, Wijesinghe.

Supervision: Nunez.

Conflict of Interest Disclosures: None reported.

References
1.
Stachler  RJ , Chandrasekhar  SS , Archer  SM ,  et al; American Academy of Otolaryngology-Head and Neck Surgery.  Clinical practice guideline: sudden hearing loss.   Otolaryngol Head Neck Surg. 2012;146(3)(suppl):S1-S35. doi:10.1177/0194599812436449 PubMedGoogle Scholar
2.
Kuhn  M , Heman-Ackah  SE , Shaikh  JA , Roehm  PC .  Sudden sensorineural hearing loss: a review of diagnosis, treatment, and prognosis.   Trends Amplif. 2011;15(3):91-105. doi:10.1177/1084713811408349 PubMedGoogle ScholarCrossref
3.
Mattox  DE , Simmons  FB .  Natural history of sudden sensorineural hearing loss.   Ann Otol Rhinol Laryngol. 1977;86(4 Pt 1):463-480. doi:10.1177/000348947708600406 PubMedGoogle Scholar
4.
Arjun  D , Neha  G , Surinder K  S , Ravi  K .  Sudden sensorineural hearing loss: prognostic factors.   Iran J Otorhinolaryngol. 2015;27(82):355-359.PubMedGoogle Scholar
5.
Cho  CS , Choi  YJ .  Prognostic factors in sudden sensorineural hearing loss: a retrospective study using interaction effects.   Braz J Otorhinolaryngol. 2013;79(4):466-470. doi:10.5935/1808-8694.20130083 PubMedGoogle ScholarCrossref
6.
Chandrasekhar  SS , Tsai Do  BS , Schwartz  SR ,  et al.  Clinical practice guideline: sudden hearing loss (update).   Otolaryngol Head Neck Surg. 2019;161(1_suppl):S1-S45. doi:10.1177/0194599819859885PubMedGoogle ScholarCrossref
7.
Rauch  SD , Halpin  CF , Antonelli  PJ ,  et al.  Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial.   JAMA. 2011;305(20):2071-2079. doi:10.1001/jama.2011.679 PubMedGoogle ScholarCrossref
8.
Capaccio  P , Ottaviani  F , Cuccarini  V ,  et al.  Genetic and acquired prothrombotic risk factors and sudden hearing loss.   Laryngoscope. 2007;117(3):547-551. doi:10.1097/MLG.0b013e31802f3c6a PubMedGoogle ScholarCrossref
9.
Olex-Zarychta  D .  Successful treatment of sudden sensorineural hearing loss by means of pharmacotherapy combined with early hyperbaric oxygen therapy: Case report.   Medicine (Baltimore). 2017;96(51):e9397. doi:10.1097/MD.0000000000009397 PubMedGoogle Scholar
10.
Bennett  MH , Kertesz  T , Perleth  M , Yeung  P , Lehm  JP .  Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus.   Cochrane Database Syst Rev. 2012;10:CD004739. doi:10.1002/14651858.CD004739.pub4 PubMedGoogle Scholar
11.
Rhee  TM , Hwang  D , Lee  JS , Park  J , Lee  JM .  Addition of hyperbaric oxygen therapy vs medical therapy alone for idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis.   JAMA Otolaryngol Head Neck Surg. 2018;144(12):1153-1161. doi:10.1001/jamaoto.2018.2133 PubMedGoogle ScholarCrossref
12.
Higgins  JPT , Savović  J , Page  MJ , Elbers  RG , Sterne  JAC . Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins  JPT , Thomas  J , Chandler  J , Cumpston  M , Li  T , Page  MJ , Welch  VA , eds.  Cochrane Handbook for Systematic Reviews of Interventions, version 6.0 (updated July 2019). Cochrane; 2019. Accessed September 17, 2021. http://www.training.cochrane.org/handbook doi:10.1002/9781119536604.ch8
13.
Higgins  JPT , Thompson  SG .  Quantifying heterogeneity in a meta-analysis.   Stat Med. 2002;21(11):1539-1558. doi:10.1002/sim.1186 PubMedGoogle ScholarCrossref
14.
Joshua  TG .  Thesis: Sudden sensorineural hearing loss. University of British Columbia; 2020. Accessed September 17, 2021. https://open.library.ubc.ca/collections/ubctheses/24/items/1.0388302
15.
Higgins  JPT , Li  T , Deeks  JJ . Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins  JPT , Thomas  J , Chandler  J , Cumpston  M , Li  T , Page  MJ , Welch  VA , eds.  Cochrane Handbook for Systematic Reviews of Interventions, version 6.0 (updated July 2019). Cochrane; 2019. Accessed September 17, 2021. http://www.training.cochrane.org/handbook
16.
Cho  I , Lee  HM , Choi  SW ,  et al.  Comparison of two different treatment protocols using systemic and intratympanic steroids with and without hyperbaric oxygen therapy in patients with severe to profound idiopathic sudden sensorineural hearing loss: a randomized controlled trial.   Audiol Neurootol. 2018;23(4):199-207. doi:10.1159/000493558 PubMedGoogle ScholarCrossref
17.
Krajčovičová  Z , Meluš  V , Zigo  R , Matisáková  I , Večeřa  J , Kaslíková  K .  Efficacy of hyperbaric oxygen therapy as a supplementary therapy of sudden sensorineural hearing loss in the Slovak Republic.   Undersea Hyperb Med. 2018;45(3):363-370.PubMedGoogle Scholar
18.
Khater  A , El-Anwar  MW , Nofal  AA , Elbahrawy  AT .  Sudden sensorineural hearing loss: comparative study of different treatment modalities.   Int Arch Otorhinolaryngol. 2018;22(3):245-249. doi:10.1055/s-0037-1605376 PubMedGoogle Scholar
19.
Topuz  E , Yigit  O , Cinar  U , Seven  H .  Should hyperbaric oxygen be added to treatment in idiopathic sudden sensorineural hearing loss?   Eur Arch Otorhinolaryngol. 2004;261(7):393-396. doi:10.1007/s00405-003-0688-6 PubMedGoogle ScholarCrossref
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close